QuantumKuano Profile Banner
Kuano Profile
Kuano

@QuantumKuano

Followers
201
Following
90
Media
0
Statuses
73

De-risking and accelerating drug discovery by combining quantum and AI

London
Joined March 2020
Don't wanna be here? Send us removal request.
@QuantumKuano
Kuano
2 years
Interested in #QuantumChemistry and #QuantumComputing? There is a PDRA available working with ourselves, Prof Andrew Green @ucl and the NQCC that could be for you.
1
1
0
@QuantumKuano
Kuano
25 days
New paper out with the Mulholland group @BristolUni!.We reveal why IRAP metabolizes oxytocin but not angiotensin IV — and how this insight drives selective inhibitor design. 📖 #DrugDiscovery #AI #QuantumChemistry #IRAP.
0
0
0
@QuantumKuano
Kuano
2 years
RT @CoSeC_community: The next @ccpbiosim industry talk will be titled "#Quantum Leaps in #Drug Discovery: The Journey of Our Startup" with….
0
1
0
@QuantumKuano
Kuano
2 years
RT @ACFInvestors: Brilliant to see @QuantumKuano included in @Siftedeu's list for the 20 European emerging cancer tech startups! @ACFinve….
0
1
0
@QuantumKuano
Kuano
2 years
RT @o2h_discovery: @QuantumKuano and @Protai stand among the distinguished winners of the o2h kickstarter competition which is exclusively….
0
1
0
@QuantumKuano
Kuano
2 years
If you have any questions feel free to DM or email at hr@kuano.ai.
0
0
0
@QuantumKuano
Kuano
2 years
The role will involve investigating how tensor networks and future quantum computers can be used to simulate the dynamics of chemical reactions, with the future aim of use in drug discovery.
1
0
0
@QuantumKuano
Kuano
2 years
RT @AscensionGrp: Great to see 3 of our #lifescience portfolio companies in @Siftedeu's 20 European emerging cancer tech startups! Check ou….
0
1
0
@QuantumKuano
Kuano
2 years
Really excited to have Charlie on the team.
@ColeGroupNCL
Cole Group
2 years
Welcome 👋 to Charlie Adams who joins us @ChemistryNCL as a @innovateuk #KTP Associate, working with @QuantumKuano to build #ML based charge models for improved pharmacophore modelling
Tweet media one
0
0
1
@QuantumKuano
Kuano
2 years
A huge thank you to our investors @Mercia_PLC, @ACFInvestors, @AscensionGrp, @o2hgroup, and other Angel investors.
0
0
5
@QuantumKuano
Kuano
2 years
We are delighted to announce the close of our £1.8M #SeedFunding round. This #investment will enable further validation of our #quantum simulation platform for #enzyme targeted #DrugDesign and #DrugDiscovery, as well as continued Company growth. more here
0
2
8
@QuantumKuano
Kuano
2 years
RT @ZymeComms: Announced today, @QuantumKuano has closed its £1.8M seed funding round to accelerate its quantum-based drug discovery and co….
0
2
0
@QuantumKuano
Kuano
2 years
RT @ColeGroupNCL: Reminder that the deadline for registering for the (free) @ccpbiosim training workshop in Leeds is 1st Sept!. We'll be th….
0
6
0
@QuantumKuano
Kuano
2 years
RT @EDYoung202: Great overview on UK quantum @eagle_labs ft. @ACFInvestors portfolio @QuantumKuano - sector needs inc. disseminating trial….
0
2
0
@QuantumKuano
Kuano
2 years
We would encourage people with mostly wetlab but some scripting/coding skills to apply.
0
0
0
@QuantumKuano
Kuano
2 years
The goal is to strengthen the interactions between our computational platform (based on simulation and AI) and experienced drug hunters.
1
0
0
@QuantumKuano
Kuano
2 years
We are looking for creative problem solvers to join our multidisciplinary team whose combined skills cover drug design, molecular modelling, cheminformatics and structural biology. Goal is for the people filling these roles to have complementary skill sets.
1
0
0
@QuantumKuano
Kuano
2 years
We are expanding our team - hiring two Drug Design Scientists to help us turn the dreams of our simulation and AI platform into novel, effective enzyme inhibitors. For details and to apply see #compchem #structuralbiology #drugdesign #SBDD #cheminformatics.
1
3
8
@QuantumKuano
Kuano
2 years
RT @QuantumDiceUK: 📢 @wenmiao_yu will be a panellist at "Decrypting the UK’s high-growth #quantum technology companies" (online, 9 Aug), al….
0
2
0
@QuantumKuano
Kuano
2 years
Great to see our work alongside all the other great work happening on Oracle.
0
1
3